M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.52 EUR -3.34% Market Closed
Market Cap: 104.5m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Maat Pharma SA
Total Equity Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Total Equity
€20.5m
CAGR 3-Years
9%
CAGR 5-Years
74%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Total Equity
€166.3m
CAGR 3-Years
29%
CAGR 5-Years
5%
CAGR 10-Years
2%
G
Genfit SA
PAR:GNFT
Total Equity
€97.4m
CAGR 3-Years
44%
CAGR 5-Years
0%
CAGR 10-Years
5%
Inventiva SA
PAR:IVA
Total Equity
-€32m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Total Equity
€175m
CAGR 3-Years
10%
CAGR 5-Years
41%
CAGR 10-Years
24%
OSE Immunotherapeutics SA
PAR:OSE
Total Equity
€81.4m
CAGR 3-Years
16%
CAGR 5-Years
5%
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Total Equity?
Total Equity
20.5m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Total Equity amounts to 20.5m EUR.

What is Maat Pharma SA's Total Equity growth rate?
Total Equity CAGR 5Y
74%

Over the last year, the Total Equity growth was -24%. The average annual Total Equity growth rates for Maat Pharma SA have been 9% over the past three years , 74% over the past five years .

Back to Top